Viewing Study NCT00277160


Ignite Creation Date: 2025-12-25 @ 2:16 AM
Ignite Modification Date: 2025-12-26 @ 12:46 AM
Study NCT ID: NCT00277160
Status: COMPLETED
Last Update Posted: 2010-10-08
First Post: 2006-01-12
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Study of Primary Prophylaxis With Neulasta (Pegfilgrastim) Versus Secondary Prophylaxis After Chemotherapy in Elderly Subjects (>/= 65 Years Old) With Cancer
Sponsor: Amgen
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2002-06
Start Date Type: None
Primary Completion Date: 2004-11
Primary Completion Date Type: ACTUAL
Completion Date: 2005-01
Completion Date Type: ACTUAL
First Submit Date: 2006-01-12
First Submit QC Date: None
Study First Post Date: 2006-01-16
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2010-10-07
Last Update Post Date: 2010-10-08
Last Update Post Date Type: ESTIMATED